Functional screening assays with neurons generated from pluripotent stem cell-derived neural stem cells
Anastasia Efthymiou1, Atossa Shaltouki, Joseph P Steiner
11National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
Journal of Biomolecular Screening
|September 11, 2013
Summary
Pluripotent stem cells (PSCs) can be differentiated into pure neural cells for drug discovery. This method enables high-throughput screening for neurodegenerative disease treatments.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Drug Discovery
Background:
- Drug discovery for neurodegenerative diseases is hindered by the lack of suitable neural cells for screening.
- Pluripotent stem cells (PSCs) offer a potential solution by enabling patient-specific neural cell generation.
Purpose of the Study:
- To develop an efficient protocol for culturing pure neuronal populations from PSCs for high-throughput screening.
- To validate the utility of PSC-derived neurons in viability and functional assays for drug discovery.
Main Methods:
- Developed a protocol for culturing pure neuronal populations in a 96-well format.
- Confirmed neuronal purity using gene expression analysis.
- Performed viability assays and live-cell imaging of organelles (nuclei, mitochondria) and neuronal maturation markers (neurite length).
- Co-cultured neurons with astrocytes to assess maturation.
Main Results:
- Successfully cultured pure neuronal populations suitable for 96-well screening.
- Demonstrated the potential of PSC-derived neurons in viability assays.
- Visualized subcellular structures and neuronal maturation markers using live-labeling and fluorescence imaging.
- Confirmed neuronal maturation through co-culture with astrocytes.
Conclusions:
- PSC-derived neurons are effective for viability and functional assays.
- This approach facilitates high-throughput screening for neurodegenerative disease therapeutics.
- Enables the use of patient-specific neurons for personalized drug discovery.
